Plant Molecular Farming Market Revenue and Forecast by 2033

08 Sep 2025

Share :

Table of Content

1. Plant Molecular Farming Market Revenue and Trends 2025 to 2033 2. What are the Key Factors Driving the Growth of the Plant Molecular Farming Market? 3. Segment Insights 4. Plant Molecular Farming Market Coverage 5. Plant Molecular Farming Market Key Players

Plant Molecular Farming Market Revenue and Trends 2025 to 2033

The global plant molecular farming market experiences growth due to breakthroughs in vaccine and therapeutic protein production. The growth of the market is attributed to the increasing demand for cost-effective, scalable, and sustainable production of biopharmaceuticals and therapeutic proteins.

What are the Key Factors Driving the Growth of the Plant Molecular Farming Market?

The plant molecular farming market is primarily driven by the need for low-cost and scalable production of biopharmaceuticals, vaccines, and therapeutic proteins. Concerns over infectious diseases and chronic health conditions are pushing the need for new drug production platforms, with plants as a sustainable alternative to traditional cell cultures. Increased investments in biotechnology research, along with advancements in genetic engineering and plant-based expression systems, are also driving the market. The shift toward greener and animal-free production methods, coupled with government support for bio-based innovations, is accelerating the development of plant-based systems, enhancing efficiency, cost-effectiveness, and global access to essential therapeutics.

Segment Insights

• By Product type, the therapeutic proteins segment held the largest share of the plant molecular farming market in 2024, driven by increased demand for affordable and scalable biopharmaceuticals.
• By Plant type/expression system, the tobacco-based systems segment dominated the market in 2024 due to their ability to provide rapid protein expression and scalability, as well as a cost advantage for producing biopharmaceuticals.
• By Production method, the transient expression segment led the market in 2024. This is because of its ability to produce biopharmaceuticals rapidly, flexibly, and at a high rate.
• By End-user, the pharmaceutical & biotechnology companies segment dominated the market by capturing the largest share in 2024, as they heavily utilize innovative plant-based systems to produce therapeutics on a large scale quickly and efficiently.

Regional Insights

North America registered dominance in the plant molecular farming market by capturing the largest revenue share in 2024. This is primarily due to its advanced biotechnology infrastructure, strong R&D efforts, and government regulations that support biopharmaceutical manufacturers. As a leader in biopharmaceutical manufacturing and molecular farming technologies, North America has a high acceptance of innovative plant-based therapeutic production systems. There are also numerous collaborations between pharmaceutical companies and research institutions, fostering a vibrant approach to plant molecular farming therapies.

Meanwhile, Asia Pacific is emerging as the fastest-growing market for plant molecular farming, driven by rising healthcare expenditures, increased investments in biopharmaceutical R&D, and enhanced biotechnology capabilities. The emergence of cost-effective plant-based production methods and government-supported policies will enable manufacturers to begin large-scale production of vaccines and therapeutic proteins.

Plant Molecular Farming Market Coverage

Recent Development

• On May 28, 2024, NewMoo introduced a soy-based liquid casein using molecular farming technology.  This innovation provides a plant-derived alternative to traditional dairy proteins, meeting the increasing demand for plant-based dairy products.  (Source: https://www.foodnavigator.com)

Plant Molecular Farming Market Key Players

• Medicago Inc
• Kentucky BioProcessing (KBP)
• Protalix Biotherapeutics
• Icon Genetics GmbH
• PlantForm Corporation
• iBio Inc.
• Ventria Bioscience
• Synthon Biopharmaceuticals
• Fraunhofer IME
• ORF Genetics
• Greenovation Biotech GmbH
• Leaf Expression Systems
• PhytoCellTech
• Biolex Therapeutics
• AgroGenesys
• Caliber Biotherapeutics
• Biocentury Plant Systems
• SemBioSys Genetics
• Explant Biotech
• PlantCell Systems

Get this report to explore global market size, share, CAGR, and trends, featuring detailed segmental analysis and an insightful competitive landscape overview @ https://www.precedenceresearch.com/sample/6723

You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com |+1 804 441 9344